Akili Inc Stock Return On Equity
Akili Inc fundamentals help investors to digest information that contributes to Akili's financial success or failures. It also enables traders to predict the movement of Akili Stock. The fundamental analysis module provides a way to measure Akili's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akili stock.
Akili |
Akili Inc Company Return On Equity Analysis
Akili's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Akili Return On Equity | -0.68 |
Most of Akili's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akili Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Akili Inc has a Return On Equity of -0.6806. This is 97.16% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 119.55% higher than that of the company.
Akili Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akili's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akili could also be used in its relative valuation, which is a method of valuing Akili by comparing valuation metrics of similar companies.Akili is currently under evaluation in return on equity category among its peers.
Akili Fundamentals
| Return On Equity | -0.68 | |||
| Return On Asset | -0.37 | |||
| Operating Margin | (28.37) % | |||
| Current Valuation | (15.56 M) | |||
| Shares Outstanding | 78.73 M | |||
| Shares Owned By Insiders | 23.21 % | |||
| Shares Owned By Institutions | 61.47 % | |||
| Number Of Shares Shorted | 271.35 K | |||
| Price To Book | 0.35 X | |||
| Price To Sales | 12.31 X | |||
| Revenue | 1.68 M | |||
| Gross Profit | (118 K) | |||
| EBITDA | (60.14 M) | |||
| Net Income | (59.49 M) | |||
| Cash And Equivalents | 45.62 M | |||
| Cash Per Share | 0.53 X | |||
| Total Debt | 15.48 M | |||
| Debt To Equity | 0.79 % | |||
| Current Ratio | 4.78 X | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | (57.87 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.61) X | |||
| Target Price | 0.65 | |||
| Number Of Employees | 68 | |||
| Beta | 1.73 | |||
| Market Capitalization | 34.1 M | |||
| Total Asset | 80.38 M | |||
| Retained Earnings | (299.78 M) | |||
| Working Capital | 65.06 M | |||
| Net Asset | 80.38 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges |